Dapagliflozin 10mg Tablets

Dapagliflozin 10mg is an SGLT2 inhibitor used in adults with type 2 diabetes and, in selected patients, for heart-failure or chronic kidney disease risk reduction according to the prescriber's plan. For glucose control, it lowers blood sugar by helping the kidneys pass excess glucose into urine. It is not for treating type 1 diabetes and should not be used for diabetic ketoacidosis. The medicine may need to be paused before major surgery, prolonged fasting, serious illness, or dehydration risk. Low blood sugar is more likely when combined with insulin or sulfonylureas.
Take Dapagliflozin 10mg once daily as prescribed, usually in the morning, with or without food. Stay hydrated, maintain the diet/activity plan, and follow sick-day or surgery-hold instructions. Do not double doses after a missed dose unless the clinician advises it.
Dapagliflozin blocks SGLT2 transporters in the kidney. This reduces glucose reabsorption, increases glucose loss in urine, and can also influence sodium-fluid handling relevant to heart and kidney outcomes.
Possible effects include increased urination, thirst, genital fungal infection, urinary infection, nausea, constipation, dizziness, low blood pressure, and low blood sugar when combined with insulin or sulfonylureas. Serious warning signs include ketoacidosis symptoms, severe dehydration, kidney problems, perineal pain/swelling, fever, or severe allergic reaction.
Review kidney function before and during therapy. Discuss use in pregnancy, breastfeeding, type 1 diabetes, recurrent genital/urinary infections, dehydration, low blood pressure, diuretic use, older age, surgery, fasting, ketogenic diet, heavy alcohol use, insulin, or sulfonylurea therapy.
Helps lower glucose through a kidney-based mechanism and may provide heart or kidney outcome benefits in selected patients beyond glucose lowering.
Dapagliflozin 10mg is used for type 2 diabetes and may also be prescribed for selected heart or kidney protection indications.
Dapagliflozin works by increasing glucose loss through urine, so urine glucose positivity is expected.
Nausea, vomiting, abdominal pain, unusual tiredness, breathing difficulty, fruity breath, or confusion need urgent assessment.
Yes. Genital fungal infections can occur because more glucose is present in urine.
Surgery, fasting, or serious illness can increase ketoacidosis risk, so temporary holding may be advised.
Alone it has low hypoglycaemia risk, but risk rises with insulin, sulfonylureas, missed meals, or alcohol.
Dapagliflozin, SGLT2 inhibitor, Type 2 diabetes medicine, Glucose in urine, Ketoacidosis warning, Genital fungal infection risk, Heart failure kidney benefit, AR: Dapagliflozin أقراص, FR: Dapagliflozin comprimé, PT: Dapagliflozin comprimido, ES: Dapagliflozin tableta, RU: Dapagliflozin таблетки, ID: Dapagliflozin, VI: Dapagliflozin viên nén, MS: Dapagliflozin, TL: Dapagliflozin tableta, ZH-SG: Dapagliflozin 片剂
International B2B Enquiry
Send a structured B2B enquiry for Dapagliflozin 10mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Dapagliflozin 10mg Tablets